With respect to breast cancer, Notch-dependent upregulation of survivin [35] may broadly suppress apoptosis, deregulate cell cycle progression [21], and ultimately promote resistance to mainstay therapeutic agents in this disease, such as taxanes [47] and DNA damaging agents [48]. The gene discussed is BIRC5; the disease is breast cancer.